http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2496873-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e610f35dc22c64ac4ca63d0bcf16b119 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate | 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6499348c63925e767caf5d945b9e7c62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de583b2d75f4c35ddf285940cc3b17a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a457cabf1edb49a68a8fe7ceb9a582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abad3624ca3062b4211b97c00fe6eb96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b1b94b09bd6d7f635a8bc50ab62b405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e633cc00913b29d892062c805d48460 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5002b28b8379dd7993d947f8fe4d792 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6baf51ca9b2f793661ac560a275e68b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5479a3d4a201e1867987dbac59509ead |
publicationDate | 2013-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2496873-C1 |
titleOfInvention | STRAIN OF ENTEROVIRUS COXSACKIE B6 SELECTIVELY INFECTING AND LYSING TUMOROUS HUMAN CELLS in vitro |
abstract | FIELD: biotechnologies. n SUBSTANCE: described strain is produced by performance of a series of adaptation passages of a parent strain of the virus ZhEV-15 Coxsackie B6 on the culture of cells HEK293 highly sensitive to this virus and the neoplastic cell line C33A (HPV-negative carcinoma of human uterine neck), with production of a new strain ZhEV-15 L of the virus Coxsackie B6. The strain selectively infects and lyses tumorous human cells and has a fragment of a genome sequence represented in the dwg. 2, being its marker criterion. The strain is deposited in the State Collection of the Federal Service for Oversight of Consumer Protection and Welfare of agents of viral infections and rickettsial diseases of the Federal Budget Institution of Science State Science Centre of Virusology and Biotechnology "Vector" under the registration number V-576. n EFFECT: invention provides for the possibility of promising development of a viral oncolytic preparation on its basis for therapy of malignant human tumours and definition of a full nucleotide sequence of its genome. n 3 dwg, 4 tbl, 2 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3674398-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2565811-C1 |
priorityDate | 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.